Foundayo vs Rybelsus: Two Oral GLP-1s Compared
April 3, 2026
Foundayo (orforglipron) and Rybelsus (oral semaglutide) are both once-daily oral GLP-1 receptor agonists approved for type 2 diabetes, but they differ in how they are taken, [...]